Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.

Abstract

Hyper-CVAD (fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate) is an intense chemotherapy regimen frequently used for hematologic malignancies including mantle cell lymphoma. To address whether treatment with hyper-CVAD impairs mobilization of peripheral blood stem cells, we retrospectively… (More)
DOI: 10.3109/10428194.2010.551154

Topics

Cite this paper

@article{Hill2011TreatmentWH, title={Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.}, author={Brian T. Hill and Lisa R. Rybicki and Stephen Smith and Robert Dean and Matt E. Kalaycio and Brad L. Pohlman and John W. Sweetenham and Shawnda Tench and Ronald M. Sobecks and Steven Andr{\`e}sen and Edward A. Copelan and Brian James Bolwell}, journal={Leukemia & lymphoma}, year={2011}, volume={52 6}, pages={986-93} }